1115 POSTER Epidermal Ggrowth Factor Receptor Inhibitor (EGFRI)-associated rash: a suggested novel management paradigm. A consensus position from the EGFRI Dermatologic Toxicity Forum

G.Giaccone; B.Melosky; M.Reck

首页> 外文期刊>European Journal of Cancer Supplements >1115 POSTER Epidermal Ggrowth Factor Receptor Inhibitor (EGFRI)-associated rash: a suggested novel management paradigm. A consensus position from the EGFRI Dermatologic Toxicity Forum

【24h】

1115 POSTER Epidermal Ggrowth Factor Receptor Inhibitor (EGFRI)-associated rash: a suggested novel management paradigm. A consensus position from the EGFRI Dermatologic Toxicity Forum

机译：1115 POSTER表皮生长因子受体抑制剂（EGFR）相关性皮疹：建议的新型治疗范例。 EGFRI皮肤毒性论坛的共识立场

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2007年第4期|共1页
作者
G.Giaccone; B.Melosky; M.Reck;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. The development of a Functional Assessment of Cancer Therapy (FACT) questionnaire to assess dermatologic symptoms associated with epidermal growth factor receptor inhibitors (FACT-EGFRI-18). [J] . Lynne I Wagner, Sara R Berg, Mona Gandhi, Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer . 2013,第4期

机译：癌症治疗功能评估（FACT）问卷的开发，以评估与表皮生长因子受体抑制剂（FACT-EGFRI-18）相关的皮肤病症状。
2. Increased infection rates associated with tetracycline therapy given for epidermal growth factor receptor inhibitor (EGFRI)-associated acneiform eruption: A retrospective study of data from two cancer centers [J] . Magnino Michele Z., Perry David J., Subramaniam Deepa S., Journal of the American Academy of Dermatology . 2020,第2期

机译：增加了与表皮生长因子受体抑制剂（EGFRI）的四环素治疗相关的感染率（EGFRI） - 分配的痤疮爆发：来自两种癌症中心的数据的回顾性研究
3. Ocular Surface Adverse Events of Systemic Inhibitors of the Epidermal Growth Factor Receptor (EGFRi): a Prospective Trial. [J] . Saint-Jean Alejandro, Eixarch Ana, Reguart Noemi, Investigative ophthalmology & visual science . 2016,第12期

机译：表皮生长因子受体的全身抑制剂的眼表面不良事件（EGFRI）：预期试验。
4. A prospective study to validate the functional assessment of cancer therapy (FACT) for epidermal growth factor receptor inhibitor (EGFRI)-induced dermatologic toxicities FACT-EGFRI 18 questionnaire: SWOG S1013 [O] . Siu-Fun Wong, Joseph M. Unger, James L. Wade, -1

机译：一项前瞻性研究以验证针对表皮生长因子受体抑制剂（EGFRI）诱发的皮肤毒性FACT-EGFRI 18的癌症治疗（FACT）的功能评估：SWOG S1013

1115 POSTER Epidermal Ggrowth Factor Receptor Inhibitor (EGFRI)-associated rash: a suggested novel management paradigm. A consensus position from the EGFRI Dermatologic Toxicity Forum

著录项

相似文献

相关主题

期刊订阅